Trends in survival after surgery for breast cancer metastatic to the brain and spinal column in medicare patients: A population-based analysis

Neurosurgery

Volumn 68, Issue 3, 2011, Pages 705-713

  Cahill, Kevin S ^a   Chi, John H ^a   Day, Art L ^a   Claus, Elizabeth B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Craniotomy; Laminectomy; Postoperative survival; Spinal fusion

Indexed keywords

AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CRANIOTOMY; DEATH; DECOMPRESSION SURGERY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LAMINECTOMY; MAJOR CLINICAL STUDY; MENINGEAL METASTASIS; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SPINE FUSION; SPINE METASTASIS; SPINE SURGERY; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT OUTCOME; TREND STUDY;

AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MEDICARE PART A; RISK ASSESSMENT; RISK FACTORS; SPINAL NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 79951769440     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820773b2     Document Type: Article

References (36)

1. Lin NU, Bellon JR, Winer EP. CNS metastases in breast cancer. J Clin Oncol. 2004;22(17):3608-3617. (Pubitemid 41103668)
2. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma: autopsy study. Cancer. 1983;52(12):2349-2354. (Pubitemid 14205961)
3. Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23(3):175-180. (Pubitemid 13035296)
4. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006;107(4):696-704. (Pubitemid 44232661)
5. Carey LA, Ewend MG, Metzger R, et al. Central nervous system metastases in women after multimodality therapy for high risk breast cancer. Breast Cancer Res Treat. 2004;88(3):273-280. (Pubitemid 40137306)
6. de la Monte SM, Hutchins GM, Moore GW. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med. 1984;76(1):11-17. (Pubitemid 14216354)
7. Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer. 2003;97(12):2972-2977. (Pubitemid 36676250)
8. Clayton AJ, Danson S, Jolly S, et al. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer. 2004;91(4):639-643. (Pubitemid 39141617)
9. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113(10):2638-2645.
10. Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol. 2006;17(6):935-944. (Pubitemid 43778983)
11. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494-500. (Pubitemid 20067825)
12. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643-648. (Pubitemid 41176016)
13. Bindal RK, Sawaya R, Leavens ME, Lee JJ. Surgical treatment of multiple brain metastases. J Neurosurg. 1993;79(2):210-216. (Pubitemid 23215837)
14. Paek SH, Audu PB, Sperling MR, Cho J, Andrews DW. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery. 2005;56(5):1021-1034.
15. Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol. 2003;61(1):73-80. (Pubitemid 36187646)
16. Korinth MC, Delonge C, Hutter BO, Gilsbach JM. Prognostic factors for patients with microsurgically resected brain metastases. Onkologie. 2002;25(5):420-425. (Pubitemid 36160180)
17. Winston KR, Walsh JW, Fischer EG. Results of operative treatment of intracranial metastatic tumors. Cancer. 1980;45(10):2639-2645. (Pubitemid 10105320)
18. Stark AM, Tscheslog H, Buhl R, Held-Feindt J, Mehdorn HM. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev. 2005;28(2):115-119. (Pubitemid 40543809)
19. Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors: analysis of factors affecting survival. Cancer. 1995;76(8):1453-1459.
20. Hirabayashi H, Ebara S, Kinoshita T, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer. 2003;97(2):476-484. (Pubitemid 36133815)
21. Chaichana KL, Pendleton C, Sciubba DM, Wolinsky JP, Gokaslan ZL. Outcome following decompressive surgery for different histological types of metastatic tumors causing epidural spinal cord compression: clinical article. J Neurosurg Spine. 2009;11(1):56-63.
22. Wronski M, Arbit E, McCormick B. Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer. 1997;80(9):1746-1754. (Pubitemid 27475932)
23. Shehadi JA, Sciubba DM, Suk I, et al. Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients. Eur Spine J. 2007;16(8):1179-1192. (Pubitemid 350104619)
24. National Cancer Institute. SEER-Medicare linked database. http://health-services.cancer.gov/seermedicare/. Accessed June 1, 2009.
25. National Cancer Institute. Overview of the SEER program. http://seer.cancer.gov/about/. Accessed June 1, 2009.
26. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8)(Suppl):IV-3-IV-18.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. (Pubitemid 17055592)
28. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
29. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11): 1130-1139. (Pubitemid 41587600)
30. Barker FG II. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer. 2004;100(5):999-1007. (Pubitemid 38222861)
31. Wronski M, Arbit E, Burt M, Galicich JH. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg. 1995;83(4):605-616.
32. Nieder C, Marienhagen K, Thamm R, Astner ST, Molls M, Norum J. Prediction of very short survival in patients with brain metastases from breast cancer. Clin Oncol (R Coll Radiol). 2008;20(5):337-339.
33. Lee SS, Ahn JH, Kim MK, et al. Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Res Treat. 2008;111(3):523-530.
34. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43(4):795-803. (Pubitemid 29152652)
35. Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA. Selecting treatment for patients with malignant epidural spinal cord compression-does age matter? Results from a randomized clinical trial. Spine (Phila Pa 1976). 2009;34(5):431-435.
36. Park BB, Uhm JE, Cho EY, et al. Prognostic factor analysis in patients with brain metastases from breast cancer: how can we improve the treatment outcomes? Cancer Chemother Pharmacol. 2009;63(4):627-633.